Sonic Incytes is dedicated to developing accessible solutions that provide health insights to enhance patient care. In response to the growing prevalence of chronic liver disease, Sonic Incytes is determined to establish liver health as a new vital sign. Their novel point-of-care ultrasound-based imaging solution, Velacur™, is redefining the standard of care in quantifying liver tissue stiffness and attenuation as an aid in the clinical management of patients with chronic liver disease.
View Top Employees from Sonic Incytes Medical Corp.Website | http://www.sonicincytes.com |
Revenue | $5 million |
Employees | 23 (19 on RocketReach) |
Founded | 2017 |
Address | 1788 W 5th Ave, Suite 309, Vancouver, British Columbia V6J 1P2, CA |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Manufacturing |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Sonic Incytes Medical Corp. employee's phone or email?
The Sonic Incytes Medical Corp. annual revenue was $5 million in 2024.
Barry Allen is the CEO of Sonic Incytes Medical Corp..
19 people are employed at Sonic Incytes Medical Corp..
Sonic Incytes Medical Corp. is based in Vancouver, British Columbia.
The NAICS codes for Sonic Incytes Medical Corp. are [334, 33].
The SIC codes for Sonic Incytes Medical Corp. are [38, 384].